| 5 | Coronavirus |
| 4 | Multiple sclerosis |
| 4 | Demyelination |
| 3 | multiple sclerosis |
| 3 | Remyelination |
| 3 | Oligodendrocyte |
| 3 | Astrocyte |
| 3 | Asthma |
| 2 | virus |
| 2 | parotid gland |
| 2 | mAb |
| 2 | influenza |
| 2 | cytokines |
| 2 | common cold |
| 2 | basement membrane |
| 2 | asthma |
| 2 | Virus |
| 2 | TNF |
| 2 | TCR |
| 2 | T cells |
| 2 | SARS, severe acute respiratory syndrome |
| 2 | Rotavirus |
| 2 | Pharyngitis |
| 2 | Oligodendrocytes |
| 2 | Microglia |
| 2 | MHC |
| 2 | MBP |
| 2 | Inflammation |
| 2 | Epidemiology |
| 2 | Cytokine |
| 2 | Canine distemper virus |
| 2 | CD13 |
| 2 | Antibodies |
| 2 | Aminopeptidase N |
| 1 | ω-hydroxylation |
| 1 | xylometazoline |
| 1 | viroporin |
| 1 | virion assembly |
| 1 | viral infections |
| 1 | viral escape |
| 1 | vasculopathy |
| 1 | vancomycin |
| 1 | type 1 fimbriae |
| 1 | tumour necrosis factor alpha (TNFα) |
| 1 | tuberculosis |
| 1 | tryptophan hydroxamate |
| 1 | trout, kidney leucocytes, interferon, induction in vitro |
| 1 | thyroiditis |
| 1 | therapeutic proteins |
| 1 | teicoplanin |
| 1 | tandem repeats |
| 1 | synergism |
| 1 | surface display of foreign epitopes |
| 1 | stress buffering |
| 1 | steroids |
| 1 | sponge medicine |
| 1 | socioeconomic status |
| 1 | social support |
| 1 | social rank |
| 1 | social integration |
| 1 | sinusitis |
| 1 | serology |
| 1 | semisynthetic polycyclic glycopeptides |
| 1 | secretory diarrhea |
| 1 | secondary metabolites |
| 1 | rotavirus |
| 1 | ribosomal A site |
| 1 | rhinorrhea |
| 1 | review |
| 1 | respiratory infections |
| 1 | release factor 2 |
| 1 | quantitative PCR |
| 1 | psychoneuroimmunology |
| 1 | proteolysis |
| 1 | protein synthesis |
| 1 | prion |
| 1 | prion disease |
| 1 | primates |
| 1 | prevalence |
| 1 | pregnancy |
| 1 | post-Communism |
| 1 | pneumonia |
| 1 | plantibodies |
| 1 | pig. |
| 1 | pharmacokinetics |
| 1 | peptide enrichment |
| 1 | pancreas |
| 1 | p.i. |
| 1 | osteosarcoma |
| 1 | oral bioavailability |
| 1 | neuroimmunology |
| 1 | neurodegenerative diseases |
| 1 | neurodegeneration |
| 1 | neuroblastoma cell |
| 1 | nervous system |
| 1 | neonates |
| 1 | natural product |
| 1 | nationalism |
| 1 | nasal spray |
| 1 | nasal decongestants |
| 1 | motor neuron disease |
| 1 | molecular farming |
| 1 | migrating action potential complexes |
| 1 | microvillus atrophy |
| 1 | microsomes |
| 1 | microglia |
| 1 | metastasis |
| 1 | metabolism |
| 1 | membranes |
| 1 | membrane topology |
| 1 | medical competence and treatment centers |
| 1 | median-effect plots |
| 1 | mass spectrometry |
| 1 | macaques and green monkeys |
| 1 | lipids |
| 1 | licorice root |
| 1 | lauric acid |
| 1 | isobologram |
| 1 | islets |
| 1 | intestinal electromyography |
| 1 | interleukin-6 |
| 1 | inflammation |
| 1 | infectious illness susceptibility |
| 1 | infectious disease |
| 1 | infancy |
| 1 | indomethacin |
| 1 | incidence |
| 1 | immunology |
| 1 | immunological findings |
| 1 | immunologic tolerance |
| 1 | hyperaccurate ribosomes |
| 1 | human immunodeficiency virus |
| 1 | histamines H1 antagonists |
| 1 | highly contagious diseases |
| 1 | hepatitis A |
| 1 | glycyrrhizic acid |
| 1 | glycopeptide-resistant bacteria |
| 1 | glutamate |
| 1 | genetic association |
| 1 | gene therapy |
| 1 | gene polymorphism |
| 1 | gene 5 protein |
| 1 | gastric ulcer |
| 1 | gastric irritancy |
| 1 | experimental autoimmune encephalomyelitis |
| 1 | exorbital lacrimal gland |
| 1 | excitotoxic amino acids |
| 1 | etanercept |
| 1 | eremomycin |
| 1 | epitope |
| 1 | enzymatic digestion |
| 1 | envelope protein |
| 1 | edible vaccines |
| 1 | drug interaction |
| 1 | dibenz(ah)antracene |
| 1 | diarrhoea |
| 1 | demyelination |
| 1 | cytoskeleton |
| 1 | cytokine regulation |
| 1 | cytochrome P-450 |
| 1 | cytarabine (ara-C) |
| 1 | cyclosporine |
| 1 | cough |
| 1 | cortisol regulation |
| 1 | corticosteroid |
| 1 | congenital |
| 1 | complement |
| 1 | complement, complement regulatory proteins, Fc receptors, HSV-1, immune evasion |
| 1 | colds |
| 1 | clinic gene expression |
| 1 | chronotherapeutics |
| 1 | chromatographic separation |
| 1 | chimeric proteins |
| 1 | cell proliferation |
| 1 | cancer |
| 1 | calves |
| 1 | calcium |
| 1 | bronchitis |
| 1 | bronchial hyperresponsiveness |
| 1 | biologically active nutrient additives |
| 1 | biochemical properties |
| 1 | benzo(a)pyrene |
| 1 | autoimmune diabetes |
| 1 | autoantibodies |
| 1 | autoaggression |
| 1 | apoptosis |
| 1 | antiviral |
| 1 | antiviral drugs |
| 1 | antiviral activity |
| 1 | antitubercular agents |
| 1 | antisense strategy |
| 1 | antileukemic activity |
| 1 | antibiotics |
| 1 | antibacterial and antiviral activity |
| 1 | anti-asthmatic agents |
| 1 | anti-HIV drugs |
| 1 | amphoteric gel |
| 1 | aminopeptidase N (APN/CD13) |
| 1 | aminoacyl-tRNA synthetase |
| 1 | allergic rhinitis |
| 1 | allergens |
| 1 | alanyl aminopeptidase |
| 1 | alanyl aminopeptidase, CD13, peptidase, peptidase inhibitor, cell proliferation, ERK2, MAP-kinase, quantitative PCR, Lightcycler |
| 1 | airborne transmission |
| 1 | aerosol behaviour |
| 1 | acinar cell culture |
| 1 | Yugoslavia |
| 1 | Xenogarft |
| 1 | Wnt-5a |
| 1 | Weight gain |
| 1 | Weanling rats |
| 1 | Virtual hits |
| 1 | Virology |
| 1 | Virological diagnosis |
| 1 | Viral vasculitis |
| 1 | Viral infectivity |
| 1 | Viral enteritis |
| 1 | Viral diarrhea |
| 1 | Vacuolar myelopathy |
| 1 | Vacuolar leucoencephalopathy |
| 1 | Vaccine |
| 1 | Vaccination |
| 1 | VSV |
| 1 | Upper respiratory tract infections |
| 1 | Ubiquitin |
| 1 | Tumor necrosis factor-α |
| 1 | Tropics |
| 1 | Transplantation |
| 1 | Transmissible gastroenteritis virus |
| 1 | Transmissible gastroenteritis coronavirus |
| 1 | Transient paralysis |
| 1 | Titanium dioxide |
| 1 | Tissue engineering |
| 1 | Tissue banking |
| 1 | Thrombopoietin |
| 1 | Throat swab |
| 1 | Thiosemicarbazones |
| 1 | Therapy |
| 1 | Tar/pitch condensation aerosol |
| 1 | TNF-α, tumor necrosis factor-α |
| 1 | TMEV |
| 1 | T-IEL |
| 1 | T lymphocytes |
| 1 | Survival rate |
| 1 | Subcutaneous emphysema |
| 1 | Stripping of Myelin Lamellae |
| 1 | Strains, Replication, ELISA, Infectivity, Pig |
| 1 | StAKoB |
| 1 | Squamous metaplasia, lun |
| 1 | Spray-dried |
| 1 | Spongy degeneration |
| 1 | Spinal cord |
| 1 | Spectrum |
| 1 | Sore throat |
| 1 | Small intestine |
| 1 | Sinusitis |
| 1 | Sino-Germany Science Center |
| 1 | Signal transduction |
| 1 | Sialic acid |
| 1 | Severity |
| 1 | Seroprevalence |
| 1 | Serological survey |
| 1 | Serbia |
| 1 | Semliki Forest virus |
| 1 | Self-assembly |
| 1 | Schwann cell |
| 1 | Schiff bases of hydroxyaminoguanidines |
| 1 | Salmonella choleraesuis |
| 1 | SFV |
| 1 | SARS |
| 1 | SARS CoV, SARS coronavirus |
| 1 | Risk factors |
| 1 | Rhinovirus |
| 1 | Rhinovirus, polymerase chain reaction, picornavirus |
| 1 | Rhinitis |
| 1 | Respiratory viruses |
| 1 | Respiratory viral infections |
| 1 | Respiratory tract diseases |
| 1 | Reporting rate |
| 1 | Reference gene |
| 1 | Recursive partitioning |
| 1 | Receptor |
| 1 | Real-time PCR |
| 1 | Reactive thrombocytosis |
| 1 | Reaction time |
| 1 | RSV |
| 1 | RNA interference (RNAi) |
| 1 | Questionnaires |
| 1 | Quantitative competitive PCR |
| 1 | Quantitative PCR |
| 1 | QSAR |
| 1 | Pulmonary keratinizing squamous cell lesion |
| 1 | Proteolytic stability |
| 1 | Protein |
| 1 | Protein assembly |
| 1 | Prospective study |
| 1 | Proliferative cell nuclear antigen (PCNA) |
| 1 | Prion protein |
| 1 | Prevalence |
| 1 | Porcine reproductive and respiratory syndrome (PRRS) |
| 1 | Population genetics |
| 1 | Polymerase chain reaction |
| 1 | Pollution abatement |
| 1 | Pleural effusion |
| 1 | Platelets |
| 1 | Pig-viruses |
| 1 | Pig-bacteria |
| 1 | Physical dysfunction |
| 1 | Phosphodiesterase inhibitor |
| 1 | Phenotype |
| 1 | Pharmacophore mapping |
| 1 | Phagocytes |
| 1 | Penetration |
| 1 | Pediatric intensive care |
| 1 | Pathogenicity |
| 1 | Pathogenesis |
| 1 | Particles, instillation |
| 1 | Particles, inhalation |
| 1 | Parkinson’s disease |
| 1 | Parainfluenza |
| 1 | Panleukopenia |
| 1 | Pandemic |
| 1 | PTSD, post-traumatic stress disorder |
| 1 | PPND |
| 1 | PP |
| 1 | PMA |
| 1 | PLP |
| 1 | PID, post inoculation day |
| 1 | PICU |
| 1 | PI-3V |
| 1 | PHA |
| 1 | PE |
| 1 | PDGFRA |
| 1 | PBS |
| 1 | PBS,pH 7.0,0.8% NaCl,0.22% Na2HPO47H2O,0.02% KH2PO4,0.02% KCl,w/w |
| 1 | PBMC |
| 1 | PBL |
| 1 | PAS, periodic acid-Schiff |
| 1 | Oligodendroglial inclusion |
| 1 | Oligodendrocyte and Astrocyte |
| 1 | Old friends |
| 1 | O -acetylated sialic acid |
| 1 | Nucleocapside |
| 1 | Novel |
| 1 | Nicotine |
| 1 | Neutralization test |
| 1 | Neuronal inclusions |
| 1 | Neurobiology |
| 1 | Neonatal diarrhea |
| 1 | Necrotizing Enterocolitis |
| 1 | Nasopharyngitis |
| 1 | Nanoparticle |
| 1 | NK |
| 1 | NF-κB |
| 1 | NASBA |
| 1 | NA |
| 1 | N279K |
| 1 | N-protein sequence |
| 1 | N-glycolyl-neuraminic acid |
| 1 | N-acetyl-neuraminic acid |
| 1 | Myelin basic protein |
| 1 | Myelin Breakdown |
| 1 | Mycoplasma pneumoniae |
| 1 | Multiple system degeneration |
| 1 | Multiple infections |
| 1 | Mucosal |
| 1 | Mucosal immunity - innate immunity - secretory IgA - TH3 - pathophysiology |
| 1 | Mouse Hepatitis Virus |
| 1 | Molecular dynamics |
| 1 | Molecular docking |
| 1 | Molecular diagnostics |
| 1 | Mock, mock inoculum |
| 1 | Minimum Standards |
| 1 | Microwave-assisted extraction |
| 1 | Microbiology |
| 1 | Microarray |
| 1 | Methionine enkephalin |
| 1 | Mesenchymal stem cells |
| 1 | Membrane protein |
| 1 | Maternal immunity |
| 1 | Marek's disease virus |
| 1 | MS |
| 1 | MOG |
| 1 | MMPs |
| 1 | MIT,3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide |
| 1 | MHV 3 |
| 1 | MAPT |
| 1 | MALT |
| 1 | MAG |
| 1 | Lyophilized |
| 1 | Lymphomeningoradiculitis |
| 1 | Lymphocyte |
| 1 | Lyme disease |
| 1 | Lupus |
| 1 | Lung |
| 1 | Lung, keratinizing squamous cell lesion |
| 1 | Lung, inhalation, different particles |
| 1 | Livestock production |
| 1 | Lipid rafts |
| 1 | Lightcycler |
| 1 | Liberty |
| 1 | Leukocyte |
| 1 | Leucine-rich-repeat-kinase-2 |
| 1 | Leucine enkephalin |
| 1 | Late onset demyelination |
| 1 | Lactobacillus salivarius |
| 1 | Lactobacillus plantarum |
| 1 | LRRK2 |
| 1 | LBW infants |
| 1 | LAMP |
| 1 | Knowledge sharing |
| 1 | Knowledge creation |
| 1 | Knowledge building |
| 1 | Key words Canine distemper virus |
| 1 | Key words Bladder |
| 1 | Keratinizing squamous cell lesion, pulmonary |
| 1 | Keratinizing cysts, lung |
| 1 | Kawasaki disease |
| 1 | KIT |
| 1 | Isothermal amplification |
| 1 | Irritant gas |
| 1 | Ion channel |
| 1 | Intramyelinic edema |
| 1 | Interleukin-6 |
| 1 | Interferon alpha |
| 1 | Interaction |
| 1 | Intensive care unit |
| 1 | Instillation, different particles |
| 1 | Inhalation, different particles |
| 1 | Influenza |
| 1 | Influenza A |
| 1 | Infections |
| 1 | Indonesia |
| 1 | Indirect ELISA |
| 1 | Incidence |
| 1 | In vivo |
| 1 | Immunosuppression |
| 1 | Immunology |
| 1 | Immunologic network |
| 1 | Immunohistology |
| 1 | Immunoglobulin isotypes |
| 1 | Immunofluorescence |
| 1 | Immunoblot technique |
| 1 | Immunobeads |
| 1 | Immunity |
| 1 | Immediate early protein |
| 1 | Ig |
| 1 | IPC |
| 1 | IFN-γ |
| 1 | IEL |
| 1 | IC50,concentration of agent that resulted in 50% of untreated culture absorbance |
| 1 | IAEA |
| 1 | Hygiene hypothesis |
| 1 | Hydroxychloroquine |
| 1 | Hydrogel |
| 1 | Hydrazides |
| 1 | Homologous |
| 1 | Heating |
| 1 | Healthy carriage |
| 1 | Healthcare personnel |
| 1 | Haplotype |
| 1 | HVA |
| 1 | HRQOL |
| 1 | HPLC, lipids |
| 1 | HLA |
| 1 | HIV-encephalopathy |
| 1 | HIV-1 |
| 1 | HDA |
| 1 | H1N1 |
| 1 | Group A beta-hemolytic streptococcus |
| 1 | Granulocyte/macrophage colony-stimulating factor |
| 1 | Graft function |
| 1 | Glycyrrhizin |
| 1 | Giant panda |
| 1 | Gerstmann-Sträussler-Scheinker syndrome |
| 1 | Germinal center |
| 1 | Germany |
| 1 | Genome |
| 1 | Genetics |
| 1 | Gene expression |
| 1 | Gastrointestinal stromal tumor |
| 1 | Gastroenteritis |
| 1 | Gas, irritant |
| 1 | Ganglioside |
| 1 | GSK-3β |
| 1 | GFD |
| 1 | GFAP |
| 1 | GAD |
| 1 | Function impairment checklist |
| 1 | Fronto-temporal dementia |
| 1 | Foreign body |
| 1 | Feline |
| 1 | Family practice |
| 1 | FTDP-17 |
| 1 | FITC |
| 1 | FACS |
| 1 | Expression, HP and LP strains, Immunoperoxidase, M and S glycoproteins |
| 1 | Expression system |
| 1 | Experimental leukoencephalitis |
| 1 | Experimental hydrocephalus |
